WeChat Mini Program
Old Version Features
Research Interests

Papers共 165 篇Author StatisticsCo-AuthorSimilar Experts

By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Meplazumab, a CD147 Antibody, for Severe COVID-19: a Double-Blind, Randomized, Placebo-Controlled, Phase 3 Clinical Trial
Huijie Bian,Liang Chen, Zheng Zhang,Ai-Dong Wen,Zhao-Hui Zheng,Li-Qiang Song,Meng-Ying Yao,Ying-Xia Liu,Xi-Jing Zhang,Hong-Lin Dong,Jian-Qi Lian,Lei Pan,Yu Liu, Xing Gu,Hui Zhao,Jing-Wen Wang, Qing-Yi Wang,Kui Zhang, Jun-Feng Jia,Rong-Hua Xie, Xing Luo,Xiang-Hui Fu,Yan-Yan Jia, Jun-Na Hou, Qiu-Yue Tan, Xiao-Xia Chen,Liu-Qing Yang,Yuan-Long Lin, Xiao-Xia Wang,Lei Zhang, Qin-Jing Zeng, Wen-Jie Li, Rui-Xuan Wang, Yang Zhang, Xiu-Xuan Sun,Bin Wang, Xu Yang,Jian-Li Jiang,Ling Li,Jiao Wu,Xiang-Min Yang,Hai Zhang,Ying Shi, Xiao-Chun Chen,Hao Tang, Hong-Wei Shi, Shuang-Shuang Liu, Yong Yang, Tian-Yi Yang,Ding Wei,Zhi-Nan Chen,Ping Zhu
Signal transduction and targeted therapyno. 1 (2025): 119-119
Cited0Views0WOSNATUREBibtex
0
0
Load More
Author Statistics

#Papers: 165

#Citation: 6721

H-Index: 39

G-Index: 80

Sociability: 6

Diversity: 4

Activity: 144

  • 合作者
  • 学生
  • 导师
No result temporarily, you can search similar Scholar with the same research interest
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn